Company intelligence / Profile preview

Wilcrest Pharma

Houston, Texas, United Stateswilcrestpharma.com ↗

Ownership: Private
Employees: ~10
Development stage: Other

Overview

Wilcrest Pharma is a newly established Houston-based FDA-regulated 503B outsourcing facility specializing in sterile and nonsterile compounded medications. The company focuses on producing high-quality antineoplastic drugs to address oncology drug shortages for health systems, clinics, pharmacies, and others. Led by CEO A.J. Day, PharmD—an industry veteran in pharmacy compounding—the firm emphasizes CGMP manufacturing practices, supply chain resilience, regulatory expertise, patient advocacy, and rapid response to medication access challenges.

Therapeutic areas: OncologyOther
Modalities: Small molecule
Industry: Contract Manufacturing Organization

Beyond the preview

Go deeper on Wilcrest Pharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Wilcrest Pharma.

Explore the full profile